PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 212 participants.

Also called NCT04011800

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 212 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04011800
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Czechia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04011800. Randomized; no masking; primary purpose treatment. Start 2021-05-01 (actual); primary completion 2025-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification.
Intervention (Procedure)
Catheter ablation
Intervention (Combination product)
Risk Factor Modification
Lead sponsor
Charles University, Czech Republic (class: other)
Collaborator
General Teaching Hospital, Prague (class: other)
Collaborator
Brno University Hospital (class: other)
Collaborator
Hospital Podlesi (class: other)
Collaborator
Regional Hospital Liberec (class: other)

Record details

Record id
cardio:ct-nct04011800
Content hash
66e3817f4c66b9ae938cca5c5b4ab7ab2558cfec1161d20c158f30e81b44c011